ATAD3A and hepatocellular carcinoma: In our present study, hypoxia-induced sorafenib resistance in HCC cells was associated with lower ATAD3A expression and upregulation of BNIP3/NIX, and loss of ATAD3A increased sorafenib insensitivity.